Get a jump start on the US trading day with Matt Miller and Vonnie Quinn on "Bloomberg Open Interest." A weight-loss game changer. Novo Nordisk wins FDA approval for a Wegovy pill, launching next month. And a billionaire bet with billions on the line — Larry Ellison’s $40 billion pledge to back Paramount’s bid for Warner Bros. No slowdown in growth: US GDP jumps to a two-year high, even as consumer confidence slips again. Plus, The Points Guy’s Brian Kelly joins Bloomberg Open Interest on navigating new travel rules this holiday season. (Source: Bloomberg)